EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro

Ananda Murali Rayapati, Chanda Chandrasekhar iD, Sudarsana Poojari iD, Bhadra Murthy Vemulapati iD

Viruses · 2025

DOI: 10.3390/v17060827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Ananda Murali Rayapati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur 522502, India. Hauptthemen laut MEDLINE: Flavonoids, Nipah Virus, Viral Envelope Proteins, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board-Extramural Research Funding (SERB-EMRF), Department of Science and Technology, India (DST-SERB-EMRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Myricetin, a flavonoid compound, was demonstrated to effectively arrest the cell-to-cell fusion and syncytial development triggered by Nipah virus (NiV) fusion (F) and attachment (G) envelope glycoproteins in vitro involving two permissive mammalian cell lines.

Methods

Time-of-addition assays were carried out using codon-optimized NiV wild type (WT) F and G plasmids followed by a challenge with the addition of myricetin 1 h and 6 h post-transfection in HEK 293T and Vero cells.

Results

Upon evaluating different myricetin concentrations, it was determined that a 100 μM concentration of myricetin effectively inhibited 64–80% of syncytia in HEK and Vero cells. Interpretation & Conclusions: In this study, we concluded that myricetin mitigated the syncytial development in HEK and Vero cell lines. Given the flavonoid attributes of myricetin which is widely present in fruits, vegetables, tea, and wine, it may be regarded as a phytonutrient and a safer antiviral alternative against Nipah virus infections. Due to the BSL-4 nature of the virus, further research involving live virus culture is necessary to confirm myricetin as a potential antiviral compound for the mitigation of pathological effects of NiV infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsNipah VirusViral Envelope ProteinsAntiviral AgentsGiant CellsAnimalsChlorocebus aethiopsHumansVero CellsHEK293 CellsVirus InternalizationHenipavirus Infections

Stichwörter der Autor:innen

F and G envelope glycoproteinsNipah virusantiviralsin vitro assaymyricetinsyncytia

Substanzen

FlavonoidsmyricetinViral Envelope ProteinsAntiviral Agents

Autor:innen und Institutionen

  • Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur 522502, India.
  • Cool Climate Oenology and Viticulture Institute, Brock University, St. Catharines, ON L2S 3A1, Canada.

ORCID-Profile: Chanda Chandrasekhar, Sudarsana Poojari, Bhadra Murthy Vemulapati

Förderung

  • Science and Engineering Research Board-Extramural Research Funding (SERB-EMRF), Department of Science and Technology, India (DST-SERB-EMRF)

Zitieren

APA

Rayapati, A. M., Chandrasekhar, C., Poojari, S., & Vemulapati, B. M. (2025). Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro. Viruses. https://doi.org/10.3390/v17060827

Vancouver

Rayapati AM, Chandrasekhar C, Poojari S, Vemulapati BM. Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro. Viruses. 2025. doi:10.3390/v17060827

BibTeX
@article{Rayapati2025,
  author = {Rayapati, Ananda Murali and Chandrasekhar, Chanda and Poojari, Sudarsana and Vemulapati, Bhadra Murthy},
  title = {Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17060827}
}
Kostenlos starten →